Lexicon Pharmaceuticals up 25% on drug trial Submitted by admin on Mon, 04/14/2014 - 08:14 Read more about Lexicon Pharmaceuticals up 25% on drug trial Source Marketwatch Headline Lexicon Pharmaceuticals up 25% on drug trial News Tags Lexicon Pharmaceuticals type 1 diabetes LX4211
The Future of Diabetes Control: Treat the Cause, Not the Symptom Submitted by admin on Thu, 12/05/2013 - 10:04 Read more about The Future of Diabetes Control: Treat the Cause, Not the Symptom Source Wall St Cheat Sheet Headline The Future of Diabetes Control: Treat the Cause, Not the Symptom News Tags diabetes Novo Nordisk Prandin Merck Lexicon Pharmaceuticals LX4211 PAZ320 Boston Therapeutics
7 Disruptive Drugs for the Next Decade Submitted by admin on Wed, 10/09/2013 - 22:42 Read more about 7 Disruptive Drugs for the Next Decade Source Motley Fool Headline 7 Disruptive Drugs for the Next Decade News Tags Tecfidera Biogen Idec Bristol-Myers Squibb Eliquis Pfizer Roche Kadcyla Immunogen sofosbuvir Gilead ibrutinib Pharmacyclics Sarepta eteplirsen LX4211 Lexicon Pharmaceuticals
Lexicon surges on diabetes drug study data Submitted by admin on Tue, 10/01/2013 - 11:05 Read more about Lexicon surges on diabetes drug study data Source Yahoo/AP Headline Lexicon surges on diabetes drug study data News Tags Lexicon diabetes LX4211
Lexicon Pharma's Never-Ending Diabetes Drug Partner Talks Submitted by admin on Thu, 08/01/2013 - 09:14 Read more about Lexicon Pharma's Never-Ending Diabetes Drug Partner Talks Source The Street Headline Lexicon Pharma's Never-Ending Diabetes Drug Partner Talks News Tags Lexicon Pharmaceuticals LX4211 type 2 diabetes diabetes
Lexicon Pharma Falls on Concerns Raised by Merck-Pfizer Diabetes Partnership Submitted by admin on Mon, 04/29/2013 - 11:48 Read more about Lexicon Pharma Falls on Concerns Raised by Merck-Pfizer Diabetes Partnership Source TheStreet.com Headline Lexicon Pharma Falls on Concerns Raised by Merck-Pfizer Diabetes Partnership News Tags Merck Pfizer Lexicon Pharmaceuticals diabetes ertugliflozin LX4211
Lexicon Pharma: Blockbuster Potential From A Diabetes Drug Submitted by admin on Tue, 10/16/2012 - 10:40 Read more about Lexicon Pharma: Blockbuster Potential From A Diabetes Drug Source TheStreet.com Headline Lexicon Pharma: Blockbuster Potential From A Diabetes Drug News Tags diabetes Lexicon Pharmaceuticals LX4211 sodium-dependent glucose transporter
Diabetes, Carcinoid Syndrome Drive Lexicon's Late-Stage Pipeline Submitted by admin on Fri, 10/12/2012 - 12:11 Read more about Diabetes, Carcinoid Syndrome Drive Lexicon's Late-Stage Pipeline Source Yahoo/Reuters Headline Diabetes, Carcinoid Syndrome Drive Lexicon's Late-Stage Pipeline News Tags diabetes Lexicon Pharmaceuticals carcinoid syndrome LX1032 LX4211
Lexicon diabetes drug meets trial goal, shares up Submitted by admin on Mon, 06/25/2012 - 11:21 Read more about Lexicon diabetes drug meets trial goal, shares up Source Reuters Headline Lexicon diabetes drug meets trial goal, shares up News Tags Lexicon diabetes LX4211
Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting Submitted by admin on Sat, 06/09/2012 - 12:29 Read more about Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting Source Yahoo/PR NewsWire Headline Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at… News Tags LX4211 Lexicon Pharmaceuticals diabetes type 2 diabetes